Positive on pharma; buy Dr Reddys, Cipla, Aurobindo: Rahul Arora

In an interview to CNBC-TV18, Rahul Arora, CEO of Nirmal Bang Institutional Equities shared his views on various stocks and sectors.

On the IT sector front, he said that the view on the sector has not changed and the dollar revenue growth will continue to remain between 3-5 percent.

Arora also said that he is positive on the pharmaceutical sector. His preferred picks in the sector are Dr Reddys Laboratories, Cipla, Aurobindo Pharma in that order.

Watch video for more...